within Pharmacolibrary.Drugs.ATC.L;

model L04AX07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.27,
    Cl             = 96 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 240 / 1000000,
    adminCount     = 1,
    Vd             = 0.053,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0055000000000000005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Dimethyl fumarate is an oral immunomodulatory drug approved for the treatment of relapsing-remitting multiple sclerosis (RRMS) and also used in the management of moderate to severe plaque psoriasis. It acts by activating the Nrf2 pathway and reducing oxidative stress and inflammation.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported for healthy adult volunteers and patients with relapsing-remitting multiple sclerosis (RRMS), following oral administration.</p><h4>References</h4><ol><li><p>Venci, JV, &amp; Gandhi, MA (2013). Dimethyl fumarate (Tecfidera): a new oral agent for multiple sclerosis. <i>The Annals of pharmacotherapy</i> 47(12) 1697–1702. DOI:<a href=&quot;https://doi.org/10.1177/1060028013509232&quot;>10.1177/1060028013509232</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24259625/&quot;>https://pubmed.ncbi.nlm.nih.gov/24259625</a></p></li><li><p>Lategan, TW, et al., &amp; Rousseau, FS (2021). Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam™ (Monomethyl Fumarate) or Tecfidera. <i>CNS drugs</i> 35(5) 567–574. DOI:<a href=&quot;https://doi.org/10.1007/s40263-021-00799-9&quot;>10.1007/s40263-021-00799-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33797063/&quot;>https://pubmed.ncbi.nlm.nih.gov/33797063</a></p></li><li><p>Sheremata, W, et al., &amp; Rammohan, KW (2015). Dimethyl fumarate for treating relapsing multiple sclerosis. <i>Expert opinion on drug safety</i> 14(1) 161–170. DOI:<a href=&quot;https://doi.org/10.1517/14740338.2015.977251&quot;>10.1517/14740338.2015.977251</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25382392/&quot;>https://pubmed.ncbi.nlm.nih.gov/25382392</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L04AX07;
